Viruses 2010, 2(1), 1-26; https://doi.org/10.3390/v2010001
Applying Genomic and Bioinformatic Resources to Human Adenovirus Genomes for Use in Vaccine Development and for Applications in Vector Development for Gene Delivery
1
Department of Bioinformatics and Computational Biology, George Mason University, 10900 University Blvd., MSN 5B3, Manassas, VA 20110, USA
2
Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA
3
Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
*
Author to whom correspondence should be addressed.
Received: 28 September 2009 / Revised: 5 December 2009 / Accepted: 17 December 2009 / Published: 6 January 2010
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
Abstract
Technological advances and increasingly cost-effect methodologies in DNA sequencing and computational analysis are providing genome and proteome data for human adenovirus research. Applying these tools, data and derived knowledge to the development of vaccines against these pathogens will provide effective prophylactics. The same data and approaches can be applied to vector development for gene delivery in gene therapy and vaccine delivery protocols. Examination of several field strain genomes and their analyses provide examples of data that are available using these approaches. An example of the development of HAdV-B3 both as a vaccine and also as a vector is presented. View Full-TextKeywords:
genomics; bioinformatics; molecular evolution; pathoepidemiology; field strain; adenovirus vaccine; human gene therapy vector; vaccine delivery vector
▼
Figures
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).